New injection after liver ablation aims to stop colorectal cancer in its tracks
Disease control
Not yet recruiting
This study tests whether a new drug (IP-001) injected into the liver after standard tumor ablation can help prevent colorectal cancer from coming back. About 717 adults with colorectal cancer that has spread only to the liver will receive either standard ablation alone or ablatio…
Phase: PHASE2, PHASE3 • Sponsor: Immunophotonics, Inc. • Aim: Disease control
Last updated May 07, 2026 18:39 UTC